Cost-Benefit of Stockpiling Drugs for Influenza Pandemic
Published Date:Aug 2005
Source:Emerg Infect Dis. 11(8):1280-1282.
Keywords: Antiviral Agents
Prevention And Control
World Health Organization
Description:We analyzed strategies for the use of stockpiled antiviral drugs in the context of a future influenza pandemic and estimated cost-benefit ratios. Current stockpiling of oseltamivir appears to be cost-saving to the economy under several treatment strategies, including therapeutic treatment of patients and postexposure prophylactic treatment of patients' close contacts.
image/gif image/jpeg text/plain text/plain
You May Also Like: